The intrainfusion rebound platelet activation during continuous prostaglandin I2 infusion occurs at the receptor level.
D000368:Aged; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D011464:Epoprostenol / Q000008:administration & dosage / Q000097:blood; D006801:Humans; D016285:Iloprost; D007262:Infusions, Intravenous; D007700:Kinetics; D010974:Platelet Aggregation / Q000187:drug effects*; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin / Q000502:physiology*; D014652:Vascular Diseases / Q000097:blood*
D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; D011464:Epoprostenol; D016285:Iloprost